Venture Map · Round
Arthex Biotech — Seed · €1.5M
Announced 2020-01-08 · Valencia · Biotech
University of Valencia spin-off Arthex Biotech (reported as 'Arthrex Biotech' in some outlets) closed a €1.5M seed round, the first investment from Invivo Partners' €40M Invivo Ventures fund. The money goes to optimising its antisense RNA therapy for myotonic dystrophy type 1, with first human trials targeted for 2022.
RoundSeed
Amount€1.5M
LeadInvivo Ventures
Date2020-01-08
CityValencia
SectorBiotech
The company
Investors 1
IInvivo Ventures (Invivo Partners)